PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: RNCOS E-Services (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

U.S. Biotechnology Firms Grew Exponentially in 2006 - Biotechnology firms in the US have shown record growth during the year 2006 through increased alliance with global drug makers
U.S. Biotechnology Firms Grew Exponentially in 2006

 

NewswireToday - /newswire/ - Delhi, New Delhi, India, 2007/05/09 - Biotechnology firms in the US have shown record growth during the year 2006 through increased alliance with global drug makers.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Year 2006 remained extraordinarily good for the US biotechnology firms. The firms were able to deliver rapid growth in revenues and earn huge profits. Biotechnology firms in US raised US$ 27.9 Billion in loans and investments in this year, maximum since 2000. This reflected the increasing alliances with drug makers of global industry.

Financings, public offerings, and revenues all showed remarkable increase as the biotechnology firms in US went on to strengthen their position as innovation engines in pharmaceutical sector, as per Ernst & Young - accounting & consulting firm – in their annual report card on this industry.

Currently, there’re 52 profitable biotechnology firms. A new genre of firms is joining biotechnology giants, such as Genentech and Amgen, and this has successfully propelled drugs through to the regulatory approval, as per Gautam Jaggi, US based analyst for Ernst & Young Global Health Sciences.

Above 4,000 biotechnology firms are into the business of manipulating cells and genes. They are manipulated largely for developing drugs for arthritis, cancer, and other diseases. Older makers of drug have paid to formulate alliances with biotechs, after depending on chemistry for developing products.

Globally, revenues from biotechnology exceeded US$ 70 Billion for the 1st time as Europe and Canada also enjoyed double digit growth. Venture funding throughout the world reached a record US$ 5.4 Billion, also total financing registered a growth of 42% to reach US $27.9 Billion. Value of biotechnology market globally is expected to be US$ 226.1 Billion by the year 2010.

According to RNCOS report “US Biotech Market Analysis”, “In 2005, total revenues generated by the US biotechnology market reached US$ 68.6 Billion, representing a CAGR of 15.16% (between 2001 and 2005). However the industry is expected to generate US$ 131.8 Billion in revenues towards the end of 2010.”

This research report on “US Biotech Market Analysis” provides extensive research and objective analysis of the Biotechnology industry in US. This report helps clients in analyzing the opportunities critical to the growth of The Biotechnology industry in US. Key issues addressed are: major market trends in the US Biotechnology industry, opportunities and challenges before the Biotechnology industry, etc.

About RNCOS E-Services Pvt Ltd.

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RNCOS E-Services (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


U.S. Biotechnology Firms Grew Exponentially in 2006

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Shushmul Maheshwari 
+91 12 04224700 press[.]rncos.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RNCOS E-Services (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RNCOS E-Services (P) Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)